Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo
{"title":"医疗补助中治疗严重低血糖的胰高血糖素产品的处方和报销","authors":"Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo","doi":"10.1001/jama.2024.25974","DOIUrl":null,"url":null,"abstract":"This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prescriptions and Reimbursement of Glucagon Products for Severe Hypoglycemia in Medicaid\",\"authors\":\"Noah M. Feder, Ryan O’Dea, Margaret Zupa, Jing Luo\",\"doi\":\"10.1001/jama.2024.25974\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.\",\"PeriodicalId\":518009,\"journal\":{\"name\":\"JAMA\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/jama.2024.25974\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jama.2024.25974","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prescriptions and Reimbursement of Glucagon Products for Severe Hypoglycemia in Medicaid
This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.